Jan 17, 2020

Aethlon Medical Announces $3.77 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Dec 17, 2019

Aethlon Medical Announces Closing of $5 Million Public Offering

Dec 13, 2019

Aethlon Medical Announces Pricing of $5 Million Public Offering

Nov 1, 2019

Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update

Oct 29, 2019

Aethlon Medical To Release Second Quarter Financial Results and Host Conference Call on November 1, 2019

Oct 14, 2019

Aethlon Announces Reverse Stock Split

Oct 7, 2019

Aethlon Medical Announces FDA Approval Of IDE For Oncology Indications

Oct 3, 2019

Aethlon Medical Receives Extension from Nasdaq to Regain Compliance with Continued Listing Requirements

Sep 24, 2019

Aethlon Announces Collaboration to Identify Exosomes Involved in Cancer Progression and Treatment Resistance

Sep 16, 2019

Aethlon Medical Receives National Cancer Institute Contract Award